News And Announcements
Latest high street casualty Office Outlet falls into administration
Office stationary retail chain Office Outlet, formerly known as Staples, on Tuesday confirmed that it has fallen into administration, putting 1,200 jobs at risk.
Wood Group returns to growth but debt cutting disappoints
Wood Group returned to growth in 2018 but said its growth cutting efforts would be slower than it planned after the merger with Amec Foster Wheeler.
Polypipe falls short of lofty expectations for 2018
Shares of Polypipe were knocked-off their perch after the company posted lower than expected full-year operating profits, but sounded a confident note on the outlook and bumped up its dividend.
Informa boosted by Morgan Stanley upgrade to 'overweight'
Morgan Stanley upped its stance on shares of events company Informa to 'overweight' from 'equalweight' on Tuesday as it highlighted decent trading and a lowly rating versus peers.
Oxford BioDynamics biomarker to be used in prostate cancer test trial
Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest ‘EpiSwitch’ biomarker signature for the blood-based diagnosis of prostate cancer in the ‘PROSTAGRAM’ trial.
ITM Power sells electrolyser to Toyota Australia
Energy storage and clean fuel company ITM Power announced on Tuesday that Toyota Australia has purchased a 0. 25MW rapid-response PEM electrolyser from it.
InstraStrata awards engineering design contract to Costain
Natural gas storage company InfraStrata has awarded an engineering design works contract to Costain, it announced on Tuesday, to enable the £65m cost savings it identified during the front-end engineering and design (FEED) process to be realised on its Islandmagee gas storage project.
Kazera upbeat on progress in Namibia
Investment company Kazera Global announced on Tuesday that the borehole drilling campaign at both the Homestead and Purple Haze deposits had been completed.
FCA fines UBS £27.6m for dire reporting of deals
The City watchdog has fined UBS more than £27m for failing to keep proper records on nearly 136m transactions over a decade.
Learning Technologies hikes dividend as profits surge
Learning Technologies reported a surge in full-year earnings on Tuesday as it hiked its dividend.
Jones Lang LaSalle to buy HFF in $2bn deal
Jones Lang LaSalle has agreed to buy capital markets services provider HFF in a cash and stock deal worth about $2bn.
ECB scepticism could threaten Deutsche-Commerzbank deal
Deutsche Bank’s mooted merger with Commerzbank could face opposition from the European Central Bank after the eurozone’s leading financial supervisor said he disliked the idea of national banking champions.
Sainsbury, Asda accuse CMA of errors over merger call
Sainsbury's and Asda have promised to invest £1bn in cutting shop prices, improve conditions for small suppliers and sell stores as they urged competition authorities to change its mind over their proposed merger.
Mondi seeks new chair as Phashwana and Williams announce retirements
Mondi is looking for a new chairman after the paper and packaging company’s joint chairs announced plans to retire.
TP Icap profit drops as broker takes goodwill charge
TP Icap’s annual profit fell as the interdealer broker took a £65m charge on the reduced value of its assets.
Bloomsbury Publishing ends year in line with expectations
Bloomsbury Publishing issued a pre-close trading update for the 12 months ended 28 February on Tuesday, saying it expected results for the year to be in line with the board's expectations.
Roche gets FDA approval for Tecentriq chemotherapy combination
Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved ‘Tecentriq’ (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for the initial treatment of adults with extensive-stage small cell lung cancer.
Cambridge Cognition wins biggest digital health contract to date
Neuroscience technology company Cambridge Cognition Holdings announced a “significant” new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.
Oncimmune acquires Protagen Diagnostics in £4.11m deal
Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4. 11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.
Standard Life Aberdeen wins dispute against Lloyds
Standard Life Aberdeen said on Tuesday that a tribunal has ruled in its favour in respect of its investment mandate dispute with Lloyds Banking Group.